Global Drugs Based on Gene Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery
LPI (LP Information)' newest research report, the “Drugs Based on Gene Therapy Industry Forecast” looks at past sales and reviews total world Drugs Based on Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Drugs Based on Gene Therapy sales for 2023 through 2029. With Drugs Based on Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs Based on Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Drugs Based on Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs Based on Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs Based on Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs Based on Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs Based on Gene Therapy.
The global Drugs Based on Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drugs Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drugs Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drugs Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drugs Based on Gene Therapy players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Bluebird bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs Based on Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery
LPI (LP Information)' newest research report, the “Drugs Based on Gene Therapy Industry Forecast” looks at past sales and reviews total world Drugs Based on Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Drugs Based on Gene Therapy sales for 2023 through 2029. With Drugs Based on Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs Based on Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Drugs Based on Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs Based on Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs Based on Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs Based on Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs Based on Gene Therapy.
The global Drugs Based on Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drugs Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drugs Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drugs Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drugs Based on Gene Therapy players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Bluebird bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs Based on Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Based on Viral
- Based on Non-viral
- Neurological Diseases
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- Bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs Based on Gene Therapy Market Size 2018-2029
2.1.2 Drugs Based on Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drugs Based on Gene Therapy Segment by Type
2.2.1 Based on Viral
2.2.2 Based on Non-viral
2.3 Drugs Based on Gene Therapy Market Size by Type
2.3.1 Drugs Based on Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Drugs Based on Gene Therapy Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Drugs Based on Gene Therapy Market Size by Application
2.5.1 Drugs Based on Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
3 DRUGS BASED ON GENE THERAPY MARKET SIZE BY PLAYER
3.1 Drugs Based on Gene Therapy Market Size Market Share by Players
3.1.1 Global Drugs Based on Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Drugs Based on Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Drugs Based on Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUGS BASED ON GENE THERAPY BY REGIONS
4.1 Drugs Based on Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Drugs Based on Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Drugs Based on Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Drugs Based on Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Drugs Based on Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drugs Based on Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Drugs Based on Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Drugs Based on Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs Based on Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Drugs Based on Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Drugs Based on Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drugs Based on Gene Therapy by Country (2018-2023)
7.2 Europe Drugs Based on Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Drugs Based on Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs Based on Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Drugs Based on Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Drugs Based on Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUGS BASED ON GENE THERAPY MARKET FORECAST
10.1 Global Drugs Based on Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Drugs Based on Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Drugs Based on Gene Therapy Forecast
10.1.3 APAC Drugs Based on Gene Therapy Forecast
10.1.4 Europe Drugs Based on Gene Therapy Forecast
10.1.5 Middle East & Africa Drugs Based on Gene Therapy Forecast
10.2 Americas Drugs Based on Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Drugs Based on Gene Therapy Market Forecast
10.2.2 Canada Drugs Based on Gene Therapy Market Forecast
10.2.3 Mexico Drugs Based on Gene Therapy Market Forecast
10.2.4 Brazil Drugs Based on Gene Therapy Market Forecast
10.3 APAC Drugs Based on Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Drugs Based on Gene Therapy Market Forecast
10.3.2 Japan Drugs Based on Gene Therapy Market Forecast
10.3.3 Korea Drugs Based on Gene Therapy Market Forecast
10.3.4 Southeast Asia Drugs Based on Gene Therapy Market Forecast
10.3.5 India Drugs Based on Gene Therapy Market Forecast
10.3.6 Australia Drugs Based on Gene Therapy Market Forecast
10.4 Europe Drugs Based on Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Drugs Based on Gene Therapy Market Forecast
10.4.2 France Drugs Based on Gene Therapy Market Forecast
10.4.3 UK Drugs Based on Gene Therapy Market Forecast
10.4.4 Italy Drugs Based on Gene Therapy Market Forecast
10.4.5 Russia Drugs Based on Gene Therapy Market Forecast
10.5 Middle East & Africa Drugs Based on Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Drugs Based on Gene Therapy Market Forecast
10.5.2 South Africa Drugs Based on Gene Therapy Market Forecast
10.5.3 Israel Drugs Based on Gene Therapy Market Forecast
10.5.4 Turkey Drugs Based on Gene Therapy Market Forecast
10.5.5 GCC Countries Drugs Based on Gene Therapy Market Forecast
10.6 Global Drugs Based on Gene Therapy Forecast by Type (2024-2029)
10.7 Global Drugs Based on Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Drugs Based on Gene Therapy Product Offered
11.1.3 Biogen Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Drugs Based on Gene Therapy Product Offered
11.2.3 Novartis Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Drugs Based on Gene Therapy Product Offered
11.3.3 Gilead Sciences Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Drugs Based on Gene Therapy Product Offered
11.4.3 Sarepta Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product Offered
11.5.3 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Drugs Based on Gene Therapy Product Offered
11.6.3 Amgen Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Drugs Based on Gene Therapy Product Offered
11.7.3 Spark Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Drugs Based on Gene Therapy Product Offered
11.8.3 Akcea Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Bluebird bio
11.9.1 Bluebird bio Company Information
11.9.2 Bluebird bio Drugs Based on Gene Therapy Product Offered
11.9.3 Bluebird bio Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bluebird bio Main Business Overview
11.9.5 Bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Drugs Based on Gene Therapy Product Offered
11.10.3 Sunway Biotech Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Drugs Based on Gene Therapy Product Offered
11.11.3 SIBIONO Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Drugs Based on Gene Therapy Product Offered
11.12.3 AnGes Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Drugs Based on Gene Therapy Product Offered
11.13.3 Orchard Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Drugs Based on Gene Therapy Product Offered
11.14.3 Human Stem Cells Institute Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drugs Based on Gene Therapy Market Size 2018-2029
2.1.2 Drugs Based on Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drugs Based on Gene Therapy Segment by Type
2.2.1 Based on Viral
2.2.2 Based on Non-viral
2.3 Drugs Based on Gene Therapy Market Size by Type
2.3.1 Drugs Based on Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Drugs Based on Gene Therapy Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Drugs Based on Gene Therapy Market Size by Application
2.5.1 Drugs Based on Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
3 DRUGS BASED ON GENE THERAPY MARKET SIZE BY PLAYER
3.1 Drugs Based on Gene Therapy Market Size Market Share by Players
3.1.1 Global Drugs Based on Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Drugs Based on Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Drugs Based on Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUGS BASED ON GENE THERAPY BY REGIONS
4.1 Drugs Based on Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Drugs Based on Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Drugs Based on Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Drugs Based on Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Drugs Based on Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drugs Based on Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Drugs Based on Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Drugs Based on Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs Based on Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Drugs Based on Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Drugs Based on Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drugs Based on Gene Therapy by Country (2018-2023)
7.2 Europe Drugs Based on Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Drugs Based on Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drugs Based on Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Drugs Based on Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Drugs Based on Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUGS BASED ON GENE THERAPY MARKET FORECAST
10.1 Global Drugs Based on Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Drugs Based on Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Drugs Based on Gene Therapy Forecast
10.1.3 APAC Drugs Based on Gene Therapy Forecast
10.1.4 Europe Drugs Based on Gene Therapy Forecast
10.1.5 Middle East & Africa Drugs Based on Gene Therapy Forecast
10.2 Americas Drugs Based on Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Drugs Based on Gene Therapy Market Forecast
10.2.2 Canada Drugs Based on Gene Therapy Market Forecast
10.2.3 Mexico Drugs Based on Gene Therapy Market Forecast
10.2.4 Brazil Drugs Based on Gene Therapy Market Forecast
10.3 APAC Drugs Based on Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Drugs Based on Gene Therapy Market Forecast
10.3.2 Japan Drugs Based on Gene Therapy Market Forecast
10.3.3 Korea Drugs Based on Gene Therapy Market Forecast
10.3.4 Southeast Asia Drugs Based on Gene Therapy Market Forecast
10.3.5 India Drugs Based on Gene Therapy Market Forecast
10.3.6 Australia Drugs Based on Gene Therapy Market Forecast
10.4 Europe Drugs Based on Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Drugs Based on Gene Therapy Market Forecast
10.4.2 France Drugs Based on Gene Therapy Market Forecast
10.4.3 UK Drugs Based on Gene Therapy Market Forecast
10.4.4 Italy Drugs Based on Gene Therapy Market Forecast
10.4.5 Russia Drugs Based on Gene Therapy Market Forecast
10.5 Middle East & Africa Drugs Based on Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Drugs Based on Gene Therapy Market Forecast
10.5.2 South Africa Drugs Based on Gene Therapy Market Forecast
10.5.3 Israel Drugs Based on Gene Therapy Market Forecast
10.5.4 Turkey Drugs Based on Gene Therapy Market Forecast
10.5.5 GCC Countries Drugs Based on Gene Therapy Market Forecast
10.6 Global Drugs Based on Gene Therapy Forecast by Type (2024-2029)
10.7 Global Drugs Based on Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Drugs Based on Gene Therapy Product Offered
11.1.3 Biogen Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Drugs Based on Gene Therapy Product Offered
11.2.3 Novartis Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Drugs Based on Gene Therapy Product Offered
11.3.3 Gilead Sciences Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Drugs Based on Gene Therapy Product Offered
11.4.3 Sarepta Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product Offered
11.5.3 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Drugs Based on Gene Therapy Product Offered
11.6.3 Amgen Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Drugs Based on Gene Therapy Product Offered
11.7.3 Spark Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Drugs Based on Gene Therapy Product Offered
11.8.3 Akcea Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Bluebird bio
11.9.1 Bluebird bio Company Information
11.9.2 Bluebird bio Drugs Based on Gene Therapy Product Offered
11.9.3 Bluebird bio Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bluebird bio Main Business Overview
11.9.5 Bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Drugs Based on Gene Therapy Product Offered
11.10.3 Sunway Biotech Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Drugs Based on Gene Therapy Product Offered
11.11.3 SIBIONO Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Drugs Based on Gene Therapy Product Offered
11.12.3 AnGes Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Drugs Based on Gene Therapy Product Offered
11.13.3 Orchard Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Drugs Based on Gene Therapy Product Offered
11.14.3 Human Stem Cells Institute Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drugs Based on Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Based on Viral
Table 3. Major Players of Based on Non-viral
Table 4. Drugs Based on Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 7. Drugs Based on Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Drugs Based on Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Drugs Based on Gene Therapy Revenue Market Share by Player (2018-2023)
Table 12. Drugs Based on Gene Therapy Key Players Head office and Products Offered
Table 13. Drugs Based on Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drugs Based on Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Drugs Based on Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Drugs Based on Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Drugs Based on Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Drugs Based on Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Drugs Based on Gene Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Drugs Based on Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Drugs Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Drugs Based on Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Drugs Based on Gene Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Drugs Based on Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Drugs Based on Gene Therapy
Table 45. Key Market Challenges & Risks of Drugs Based on Gene Therapy
Table 46. Key Industry Trends of Drugs Based on Gene Therapy
Table 47. Global Drugs Based on Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Drugs Based on Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Drugs Based on Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Drugs Based on Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 52. Biogen Drugs Based on Gene Therapy Product Offered
Table 53. Biogen Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 57. Novartis Drugs Based on Gene Therapy Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 62. Gilead Sciences Drugs Based on Gene Therapy Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 67. Sarepta Therapeutics Drugs Based on Gene Therapy Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 77. Amgen Drugs Based on Gene Therapy Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 82. Spark Therapeutics Drugs Based on Gene Therapy Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 87. Akcea Therapeutics Drugs Based on Gene Therapy Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. Bluebird bio Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 92. Bluebird bio Drugs Based on Gene Therapy Product Offered
Table 93. Bluebird bio Main Business
Table 94. Bluebird bio Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 97. Sunway Biotech Drugs Based on Gene Therapy Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 102. SIBIONO Drugs Based on Gene Therapy Product Offered
Table 103. SIBIONO Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 107. AnGes Drugs Based on Gene Therapy Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 112. Orchard Therapeutics Drugs Based on Gene Therapy Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 117. Human Stem Cells Institute Drugs Based on Gene Therapy Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Human Stem Cells Institute Latest Developments
Table 1. Drugs Based on Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Based on Viral
Table 3. Major Players of Based on Non-viral
Table 4. Drugs Based on Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 7. Drugs Based on Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Drugs Based on Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Drugs Based on Gene Therapy Revenue Market Share by Player (2018-2023)
Table 12. Drugs Based on Gene Therapy Key Players Head office and Products Offered
Table 13. Drugs Based on Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drugs Based on Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Drugs Based on Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Drugs Based on Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Drugs Based on Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Drugs Based on Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Drugs Based on Gene Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Drugs Based on Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Drugs Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Drugs Based on Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Drugs Based on Gene Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Drugs Based on Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Drugs Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Drugs Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Drugs Based on Gene Therapy
Table 45. Key Market Challenges & Risks of Drugs Based on Gene Therapy
Table 46. Key Industry Trends of Drugs Based on Gene Therapy
Table 47. Global Drugs Based on Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Drugs Based on Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Drugs Based on Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Drugs Based on Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 52. Biogen Drugs Based on Gene Therapy Product Offered
Table 53. Biogen Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 57. Novartis Drugs Based on Gene Therapy Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 62. Gilead Sciences Drugs Based on Gene Therapy Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 67. Sarepta Therapeutics Drugs Based on Gene Therapy Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 77. Amgen Drugs Based on Gene Therapy Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 82. Spark Therapeutics Drugs Based on Gene Therapy Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 87. Akcea Therapeutics Drugs Based on Gene Therapy Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. Bluebird bio Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 92. Bluebird bio Drugs Based on Gene Therapy Product Offered
Table 93. Bluebird bio Main Business
Table 94. Bluebird bio Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 97. Sunway Biotech Drugs Based on Gene Therapy Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 102. SIBIONO Drugs Based on Gene Therapy Product Offered
Table 103. SIBIONO Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 107. AnGes Drugs Based on Gene Therapy Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 112. Orchard Therapeutics Drugs Based on Gene Therapy Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 117. Human Stem Cells Institute Drugs Based on Gene Therapy Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Human Stem Cells Institute Latest Developments
LIST OF FIGURES
Figure 1. Drugs Based on Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs Based on Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drugs Based on Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drugs Based on Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Drugs Based on Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drugs Based on Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Drugs Based on Gene Therapy in Neurological Diseases
Figure 11. Global Drugs Based on Gene Therapy Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Drugs Based on Gene Therapy in Cancer
Figure 13. Global Drugs Based on Gene Therapy Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Drugs Based on Gene Therapy in Other
Figure 15. Global Drugs Based on Gene Therapy Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Drugs Based on Gene Therapy Market Size Market Share by Application in 2022
Figure 17. Global Drugs Based on Gene Therapy Revenue Market Share by Player in 2022
Figure 18. Global Drugs Based on Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Drugs Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Drugs Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Drugs Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Drugs Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Drugs Based on Gene Therapy Value Market Share by Country in 2022
Figure 24. United States Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Drugs Based on Gene Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Drugs Based on Gene Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Drugs Based on Gene Therapy Market Size Market Share by Application in 2022
Figure 31. China Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Drugs Based on Gene Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Drugs Based on Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Drugs Based on Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Drugs Based on Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs Based on Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drugs Based on Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drugs Based on Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Drugs Based on Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drugs Based on Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Drugs Based on Gene Therapy in Neurological Diseases
Figure 11. Global Drugs Based on Gene Therapy Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Drugs Based on Gene Therapy in Cancer
Figure 13. Global Drugs Based on Gene Therapy Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Drugs Based on Gene Therapy in Other
Figure 15. Global Drugs Based on Gene Therapy Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Drugs Based on Gene Therapy Market Size Market Share by Application in 2022
Figure 17. Global Drugs Based on Gene Therapy Revenue Market Share by Player in 2022
Figure 18. Global Drugs Based on Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Drugs Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Drugs Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Drugs Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Drugs Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Drugs Based on Gene Therapy Value Market Share by Country in 2022
Figure 24. United States Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Drugs Based on Gene Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Drugs Based on Gene Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Drugs Based on Gene Therapy Market Size Market Share by Application in 2022
Figure 31. China Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Drugs Based on Gene Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Drugs Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Drugs Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Drugs Based on Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Drugs Based on Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
